Get a new prescription or refill of Farxiga today from a board-certified primary care doctor online.* About Farxiga Farxiga is considered a sodium-glucose cotransporter 2 (SGLT2) inhibitor, which functions by aiding the kidneys in removing glucose from the body through urine
Simultaneously, GLP-1 receptor activation stimulates glucose-dependent insulin release, suppresses inappropriate glucagon secretion, and slows gastric emptying
The subscription typically provides your medication and support and guidance from licensed professionals
Investigating How GLP-1 May Contribute to Hair Loss Though not a direct side effect, a few mechanisms might explain how GLP-1 medications could indirectly contribute to hair loss
Hung V, Udeshi ND, Lam SS, Loh KH, Cox KJ, Pedram K, Carr SA, Ting AY
Patients with favorable GLP1R variants often experience appetite suppression at lower doses, while those with FTO genetic risk variants may benefit from higher doses or combination therapy